Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q3

2796.TEDINET S100QKFA
Period2022-06-01 → 2023-02-28
Filed2023-04-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥38.7bn2022-06-01 → 2023-02-28Cons.Net sales
Revenue¥51.6bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥38.6bn2021-06-01 → 2022-02-28Cons.Net sales
Operating income¥896m2022-06-01 → 2023-02-28Cons.Operating income
Operating income¥1.0bn2021-06-01 → 2022-02-28Cons.Operating income
Ordinary income¥890m2022-06-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.5bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2021-06-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥722m2022-06-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥967m2021-06-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥208m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥447m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥322m2021-06-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥218m2022-06-01 → 2023-02-28Cons.Profit loss
Net income¥326m2021-06-01 → 2022-02-28Cons.Profit loss
Total assets¥22.9bnat 2023-02-28Cons.Assets
Total assets¥23.7bnat 2022-05-31Cons.Assets
Total assets¥23.8bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥16.1bnat 2023-02-28Cons.Liabilities
Total liabilities¥17.0bnat 2022-05-31Cons.Liabilities
Net assets / equity¥6.8bnat 2023-02-28Cons.Net assets
Net assets / equity¥6.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥6.6bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.4bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥22.242022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.452022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.992021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.62021-06-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.682021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.892022-06-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.292021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.162021-06-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio28.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio26.9%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.4%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥37m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥226m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2023-02-28−¥170m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2023-02-28¥56m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.1bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥70m
—segment totalrevenue2022-06-01 → 2023-02-28¥38.2bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥38.2bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2022-02-28¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2022-02-28¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2022-02-28¥22m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-02-28−¥235m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2021-06-01 → 2022-02-28¥5.7bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2021-06-01 → 2022-02-28¥5.7bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2021-06-01 → 2022-02-28−¥151m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2021-06-01 → 2022-02-28¥516m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2021-06-01 → 2022-02-28¥516m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2021-06-01 → 2022-02-28¥71m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2021-06-01 → 2022-02-28¥31.4bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2021-06-01 → 2022-02-28¥31.4bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2021-06-01 → 2022-02-28¥1.2bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2021-06-01 → 2022-02-28¥377m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2021-06-01 → 2022-02-28¥377m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2021-06-01 → 2022-02-28¥48m
—segment totalrevenue2021-06-01 → 2022-02-28¥38.0bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥38.0bn
—segment totalsegment profit2021-06-01 → 2022-02-28¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥38.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥38.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 387
ItemContextValueUnit
Current portion of bondsPrior1YearInstant－JPY
Current portion of bondsCurrentQuarterInstant1482000000JPY
Current portion of long term loans payablePrior1YearInstant2276000000JPY
Current portion of long term loans payableCurrentQuarterInstant2019000000JPY
Income taxes payablePrior1YearInstant429000000JPY
Income taxes payableCurrentQuarterInstant106000000JPY
Provision for bonusesPrior1YearInstant46000000JPY
Provision for bonusesCurrentQuarterInstant283000000JPY
Provision for loss on store closingPrior1YearInstant50000000JPY
Provision for loss on store closingCurrentQuarterInstant26000000JPY
Other clPrior1YearInstant1564000000JPY
Other clCurrentQuarterInstant1095000000JPY
Current liabilitiesPrior1YearInstant8477000000JPY
Current liabilitiesCurrentQuarterInstant9442000000JPY
Bonds payablePrior1YearInstant1482000000JPY
Bonds payableCurrentQuarterInstant－JPY
Long term loans payablePrior1YearInstant5603000000JPY
Long term loans payableCurrentQuarterInstant5262000000JPY
Net defined benefit liabilityPrior1YearInstant781000000JPY
Net defined benefit liabilityCurrentQuarterInstant817000000JPY
Asset retirement obligations nclPrior1YearInstant111000000JPY
Asset retirement obligations nclCurrentQuarterInstant113000000JPY
Other nclPrior1YearInstant592000000JPY
Other nclCurrentQuarterInstant465000000JPY
Noncurrent liabilitiesPrior1YearInstant8570000000JPY
Noncurrent liabilitiesCurrentQuarterInstant6659000000JPY
LiabilitiesPrior1YearInstant17047000000JPY
LiabilitiesCurrentQuarterInstant16101000000JPY
Capital stockPrior1YearInstant1274000000JPY
Capital stockCurrentQuarterInstant1298000000JPY
Capital surplusPrior1YearInstant1529000000JPY
Capital surplusCurrentQuarterInstant1553000000JPY
Retained earningsPrior1YearInstant3811000000JPY
Retained earningsCurrentQuarterInstant3889000000JPY
Treasury stockPrior1YearInstant-210000000JPY
Treasury stockCurrentQuarterInstant-210000000JPY
Shareholders equityPrior1YearInstant6405000000JPY
Shareholders equityCurrentQuarterInstant6531000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-0JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-0JPY
Remeasurements of defined benefit plansPrior1YearInstant-5000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-6000000JPY
Valuation and translation adjustmentsPrior1YearInstant-6000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-7000000JPY
Subscription rights to sharesPrior1YearInstant208000000JPY
Subscription rights to sharesCurrentQuarterInstant208000000JPY
Non controlling interestsPrior1YearInstant91000000JPY
Non controlling interestsCurrentQuarterInstant101000000JPY
Net assetsPrior1YearInstant6699000000JPY
Net assetsCurrentQuarterInstant6833000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2023-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-06-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass